There were 246 press releases posted in the last 24 hours and 442,483 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image